DEA to Temporarily Schedule Kratom Compound 7-OH as Controlled Substance

The U.S. Drug Enforcement Administration announced that it will temporarily schedule the synthetic opioid known colloquially as “gas station heroin” as a controlled substance. The decision follows a series of investigations that linked the drug’s rapid rise in street use to a spike in overdose deaths across several states. By placing the compound on the temporary schedule, the agency aims to curb its distribution while it gathers additional data on its pharmacology and public‑health impact.

The move is seen as a significant win for the Marijuana and Hemp Advocacy Group (MAHA) and the mainstream kratom industry, both of which have long campaigned for clearer regulatory frameworks. MAHA has argued that a controlled‑substance designation for the opioid will help protect consumers and reduce the illicit market that often competes with legal kratom products. The kratom community, which relies on a regulated supply chain to maintain product safety, welcomed the ruling as a step toward greater legitimacy for their industry.

While the temporary scheduling will restrict the drug’s manufacture, distribution, and possession, the DEA has indicated that the measure is provisional pending further research. Stakeholders in the kratom sector expect the ruling to reduce the risk of cross‑market contamination and to support ongoing efforts to establish standardized testing protocols for herbal supplements.